CohBar (NASDAQ: CWBR)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-15 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.040 | -0.040 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of CohBar (NASDAQ: CWBR) through any online brokerage.
Other companies in CohBar’s space includes: Allena Pharma (NASDAQ:ALNA), Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Midatech Pharma (NASDAQ:MTP) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
The latest price target for CohBar (NASDAQ: CWBR) was reported by WBB Securities on Wednesday, August 11, 2021. The analyst firm set a price target for 5.00 expecting CWBR to rise to within 12 months (a possible 2653.30% upside). 1 analyst firms have reported ratings in the last year.
The stock price for CohBar (NASDAQ: CWBR) is $0.1816 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for CohBar.
CohBar’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for CohBar.
CohBar is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.